A Comparison of the Post-C/S Analgesic Effects of Neuraxial Duramorph vs Bilateral TAP Block With Liposomal Bupivacaine
Status:
Terminated
Trial end date:
2020-06-30
Target enrollment:
Participant gender:
Summary
The primary objective is to reduce or eliminate the use of all narcotics/opiates for post
Cesarean section pain management. The investigators hypothesize that in comparison with
epidural or intrathecal Duramorph, a TAP block with liposomal bupivacaine (Exparel) will
provide better, longer-acting pain control and will significantly reduce the use of
post-operative IV or p.o. opiates. This is a prospective, randomized clinical trial.